Open for inclusion

A first-in-human, multicenter, open-label, phase 1 study in patients with advanced and/or refractory

Cancer type: Solide tumores

Phase: I

Principal Investigator: Yachnin Jeffrey

Country: SE

Keywords: Swede, Stockholm, ATOR-1015

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03782467?term=ator-1015&rank=1